UPDATED Jun 26, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$29.71 | 1.7% | 68.8% | US$4.9b | US$28.75 | PS25.4x | E84.4% | n/a | Semiconductors | ||
EH | US$13.64 | -6.0% | -5.7% | US$863.2m | US$24.98 | PS40x | E74.3% | n/a | Capital Goods | ||
ATAT | US$18.07 | 0.4% | 11.7% | US$2.5b | US$27.17 | PE18.5x | E21.7% | 0.8% | Consumer Services | ||
TBBB | US$23.03 | 4.9% | n/a | US$2.6b | US$27.05 | PS1x | E100.1% | n/a | Consumer Retailing | ||
PDD | US$138.23 | -4.1% | 96.9% | US$194.4b | US$204.98 | PE17.5x | E23.2% | n/a | Retail | ||
GCT | US$29.43 | -2.5% | 284.2% | US$1.2b | US$52.33 | PE11.4x | E21.3% | n/a | Retail | ||
CG | US$39.60 | 0.1% | 26.9% | US$14.3b | US$48.47 | PS6.4x | E23.6% | 3.5% | Diversified Financials | ||
SMCI | US$831.16 | -9.7% | 252.3% | US$49.4b | US$1,032.47 | PE46.4x | E40.2% | n/a | Tech | ||
DUOL | US$203.89 | -3.7% | 42.2% | US$8.8b | US$252.23 | PE192.8x | E48.0% | n/a | Consumer Services | ||
BRDG | US$7.33 | 2.4% | -34.0% | US$878.4m | US$9.88 | PB3.4x | E98.2% | 9.0% | Diversified Financials | ||
MAX | US$13.08 | -23.8% | 39.7% | US$940.9m | US$25.33 | PS1.7x | E88.1% | n/a | Media | ||
ZKH | US$3.90 | 10.8% | n/a | US$628.2m | US$15.74 | PB1.4x | E104.4% | n/a | Capital Goods | ||
HOFV | US$2.95 | -1.7% | -73.7% | US$18.9m | US$8.00 | PB0.2x | E71.1% | n/a | Consumer Services | ||
HNVR | US$16.48 | 1.2% | -6.7% | US$119.4m | US$18.50 | PB0.6x | E20.9% | 2.4% | Banks | ||
CARG | US$25.50 | 0.8% | 12.0% | US$2.6b | US$26.62 | PE73.2x | E30.0% | n/a | Media | ||
SPRY | US$8.08 | 0% | 22.8% | US$741.2m | US$19.00 | PS78291.4x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
ESTA | US$43.59 | 0.2% | -36.3% | US$1.2b | US$65.14 | PS7.7x | E68.2% | n/a | Healthcare | ||
EVOK | US$0.54 | 7.2% | -66.6% | US$4.3m | US$7.00 | PB1.3x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
LOOP | US$2.15 | -0.9% | -32.2% | US$101.7m | US$7.25 | PS668x | E70.8% | n/a | Materials | ||
HSAI | US$4.35 | -7.4% | -58.5% | US$534.1m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
MYO | US$3.00 | -7.1% | 499.9% | US$87.6m | US$6.60 | PS4.4x | E66.0% | n/a | Healthcare | ||
HSCS | US$5.18 | 1.4% | -94.4% | US$3.5m | US$67.50 | PS182.6x | E66.8% | n/a | Healthcare | ||
RYAN | US$57.59 | 6.8% | 30.8% | US$15.4b | US$58.08 | PE107.8x | E56.6% | 0.8% | Insurance | ||
WULF | US$4.59 | 1.8% | 165.3% | US$1.6b | US$5.70 | PS15.3x | E151.8% | n/a | Software |